BUZZ-U.S. STOCKS ON THE MOVE- Automobile stocks, Kite Pharma, Zimmer

(Adds Zimmer Holdings, Kite Pharma (NasdaqGS: KITE - news) , automobile stocks; Updates Novartis (Xetra: 904278 - news) , Cempra (NasdaqGS: CEMP - news) ) (For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s)

Energy sector stocks led a broad selloff on Wall Street on Monday as crude prices fell to fresh five-and-a-half-year lows and a strong dollar also weighed on other commodities. The Dow Jones industrial average was down 1.40 percent at 17,583.4, the S&P 500 was down 1.48 percent at 2,027.79 and the Nasdaq Composite was down 38.95 points, or 0.82 percent, to 4,687.86

** FORD MOTOR CO (NYSE: F - news) , $14.8, -3.65 pct

** FIAT CHRYSLER AUTOMOBILES NV, $11.26, -3.68 pct

** HONDA MOTOR CO, $29.04, -1.86 pct

The December U.S. sales of all three automakers fell short of market estimates. Industry executives and analysts cautioned that sales growth will slow this year after five years of rapid recovery from the recession.

** ZIMMER HOLDINGS INC (NYSE: ZMH - news) , $115.74, +2.80 pct

Analysts at J.P. Morgan (Other OTC: MGHL - news) upgraded the orthopaedic device maker's shares to "overweight" from "neutral" and raised their price target on it to $136 from $120 - the highest among 25 brokerages covering the stock.

Zimmer could benefit from reduced dis-synergy risk and improved industry pricing over time if Stryker Corp pursues and ultimately reaches an agreement with Smith & Nephew (LSE: SN.L - news) Plc, the analysts wrote.

The stock touched its year-high of $117.19.

** KITE PHARMA INC, $64.686, +6.73 pct

Amgen Inc (Xetra: 867900 - news) and Kite Pharma said they entered into a deal to develop and market cancer immunotherapies using Amgen's cancer targets and Kite's technology platform.

** STEREOTAXIS INC (NasdaqCM: STXS - news) , $1.87, +21.43 pct

The U.S. Food and Drug Administration approved the medical device maker's catheter device, Vdrive with catheter advancement system, for sale in the country.

The company also received an approval from Japan Pharmaceuticals and Medical Devices Agency for Odyssey data management products.

** CONATUS PHARMACEUTICALS INC (NasdaqGM: CNAT - news) , $10.05, +24.23 pct

The biotechnology company said it would present results from three clinical trials of its lead drug Emricasan on Thursday. Conatus said it would present results from a mid-stage study of the drug in patients with acute-on-chronic liver failure.

** ISIS PHARMACEUTICALS INC (Stuttgart: ISI.SG - news) , $67.3, +9.31 pct

Johnson & Johnson (NYSE: JNJ - news) will pay the biotech company up to $835 million for an option to license three drugs targeting autoimmune diseases in the bowel.

** BRAINSTORM CELL THERAPEUTICS INC (NasdaqCM: BCLI - news) , $6.01, -19.87 pct

The Israeli stem cell therapy developer's stock rose 93 percent in past two trading days as data on mid-stage study of the company's stem cell therapy in patients with amytrophic lateral sclerosis is expected on Monday.

** ROYAL DUTCH SHELL PLC (Xetra: R6C1.DE - news) , $63.76, -4.81 pct

** TOTAL SA (Paris: FR0000120271 - news) , $47.84, -6.49 pct

** BP PLC, $35.85, -5.95 pct

** STATOIL ASA (Xetra: 675213 - news) , $16.49, -5.34 pct

** VALE SA, $7.71, -2.90 pct

** BHP BILLITON LTD, $45.6, -4.08 pct

** EXXON MOBIL CORP, $89.95, -3.10 pct

** CHEVRON CORP, $107.93, -4.13 pct

** PETROBRAS SA, $6.2, -8.28 pct

U.S.-listed stocks of the world's biggest oil and gas producers were down premarket after oil prices dropped to fresh five-and-a-half-year lows. Oil prices have been dipping on concerns over a surplus of global supplies and lackluster demand, losing more than half their value since a peak in June last year.

** CEMPRA INC, $26.0782, +13.93 pct

The antibiotic drug developer moved a step closer to approval for its lead antibiotic, solithromycin, after an oral version of the potential blockbuster met the main goal in a late-stage trial.

** NATIONAL BANK OF GREECE SA, $1.68, -8.70 pct

Political uncertainty in Greece may force the European Central Bank to start quantitative easing as debate around the possibility of elections later this month resulting in the country leaving the euro zone picked up again.

Euro fell to $1.18605 in early Asian trading on Monday, its weakest level since March 2006.

** BREITBURN ENERGY PARTNERS LP, $7.0799, -7.21 pct

The oil and gas company said on Friday it expected 2015 production of 19.5-20.7 million barrels of oil equivalent (boe), up from an estimated 14.1 million boe for 2014. Breitburn forecast oil and gas capital expenses to fall to $200 million in 2015 from an estimated $375 million in 2014.

** CERUS CORP, $6.7165, +3.09 pct

The biomedical product maker said red blood cells treated with its Intercept Blood System for acute anemia in cardiovascular surgery patients met the main goal in an European late-stage trial.

** CINEMARK HOLDINGS INC (NYSE: CNK - news) , $33.94, -2.78 pct

The movie theater chain's shares could rise more than 25 percent over the next year, Barron's reported in its Jan. 5 edition. (Compiled by Lehar Maan; Editing by Joyjeet Das)